|
Helper Plasmids for Rescue of Respiratory Syncytial Virus
ApplicationPlasmids rescuing recombinant syncytial virus for RSV research and vaccine development.Key BenefitsAllow expression and recombination in vero cells.Optimized for human codon bios to increase expression in mammalian cells.Market SummaryRespiratory syncytial virus (RSV) is the major cause of acute lower respiratory tract infections in infants...
Published: 2/13/2025
Contributor(s): Martin Moore
|
|
Untagged RSV A2-line 19F Strain Generated from BAC-RSV Clone
ApplicationStrain of respiratory syncytial virus (RSV) for vaccine and therapeutic research and development.Key Benefits High titer RSV strain. Strain A2-line 19F recapitulates human RSV infection in mouse models making it useful for initial vaccine studies. Market SummaryRespiratory syncytial virus (RSV) is the leading cause of lower respiratory tract...
Published: 2/13/2025
Contributor(s): Martin Moore
|
|
Respiratory syncytial virus (RSV) Reporter Plasmid for High Throughput Drug Screening
Application
Bioluminescence reporter for high throughput respiratory syncytial virus (RSV) drug discovery.
Key Benefits
Simple luciferase readout marker indicates RSV replication activity.
Market Summary
RSV is a ubiquitous respiratory pathogen worldwide. It is the most common cause of severe lower respiratory tract disease among infants and young...
Published: 2/13/2025
Contributor(s): Martin Moore, Anne Hotard (Lopez-Ona), Richard Plemper
|
|
Respiratory Syncytial Virus (RSV) Luminescent Reporter Strain
Application
Modified respiratory syncytial virus (RSV) expressing a bioluminescent reporter protein for high throughput screening, vaccine development, and drug discovery. Plasmid encoding virus also available.
Key Benefits
Provides a new high throughput screening tool for RSV vaccine development and drug discovery.
Bioluminescent assays outperform...
Published: 2/13/2025
Contributor(s): Richard Plemper, Martin Moore
|
|
Respiratory Syncytial Virus (RSV) Fluorescent Reporter Strain
Application
Modified RSV incorporating a red fluorescent reporter protein for vaccine, drug and biologic research & development.
Key Benefits
Provides new and needed screening tool for RSV research.
Fluorescent protein included has better in vivo imaging capabilities than other more commonly used fluorescent proteins.
Market Summary
RSV...
Published: 2/13/2025
Contributor(s): Martin Moore, Anne Hotard (Lopez-Ona)
|
